T-BAL CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Testing Services: Multi-omics and spatial omics testing, integrating genomic, proteomic, metabolomic, and lipidomic data.
ODM/OEM: This service provides microreactor continuous process development, nano-scale active ingredient encapsulation, and pilot production services, supporting pharmaceutical, biotech, and functional food companies to enhance R&D efficiency and product stability.
ODM/OEM: This service provides microreactor continuous process development, nano-scale active ingredient encapsulation, and pilot production services, supporting pharmaceutical, biotech, and functional food companies to enhance R&D efficiency and product stability.
The content above was translated by Ai
Founded Year
2017
Unified Business No.
59224250
Status
Active
Number of Employees
0
Total Paid-in
Capital
39,435,685 (NT$)
Location of Company
Taiwan
, Taichung City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
T-BAL CO., LTD. is the first enterprise in Taiwan focusing primarily on providing comprehensive lipidomics measurement services. Through the exclusive representation of the high-end "shotgun liquid chromatography-tandem mass spectrometry" (Shotgun LC-MS/MS) technology developed by the German company Lipotype GmbH Ltd., comprehensive lipidomics analysis can be obtained in a "high-throughput" (High Through-put) manner. This technological advantage is far ahead of global industry peers. In addition to the exclusive agency of Lipotype GmbH Ltd.'s analytical technology, the "comprehensive lipid big data analysis" service exclusively developed by T-BAL CO., LTD., and the "cross-data platform" genomic data integration service, have enriched the connotation of precision medicine.
The content above was translated by Ai
